Diplomat Pharmacy,Inc. (NYSE:DPLO) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February22, 2019, Jeff Park provided the Board of Directors (“the Board”) of Diplomat Pharmacy,Inc. (the “Company”) with notice of his resignation from the Board, effective immediately.
A copy of the Company’s news release regarding the foregoing matter is attached hereto as Exhibit99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
|
ExhibitNo. |
Description |
|
99.1 |
Company news release dated February28, 2019 |
Diplomat Pharmacy, Inc. Exhibit
EX-99.1 2 a19-5536_1ex99d1.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE: CONTACT: Feb. 28,…
To view the full exhibit click here
About Diplomat Pharmacy,Inc. (NYSE:DPLO)
Diplomat Pharmacy, Inc. operates a specialty pharmacy business, which stocks, dispenses and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. The Company’s primary focus is on medication management programs for individuals with chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy, and various other serious and/or long-term conditions. The Company operates through specialty pharmacy services segment. The Company offers various services, such as specialty drug dispensing, retail specialty services, hospital and health system services, and hub services. Its specialty drug dispensing services include patient care coordination, clinical services, compliance and persistency programs, patient financial assistance, specialty pharmacy training/consulting (Diplomat University), benefits investigation, prior authorization and risk evaluation and medication strategy (REMS).